Nagendran Sukumar
Insider CIK 1665124 · AVXS Sr. VP & Chief Medical Officer · SLDB Director · TSHA President and Head of R&D, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TSHA Taysha Gene Therapies, Inc | S Sale | 2026-07-10 | 2026-07-10 | 200,000 | $6.24 | $1.25M | 936,410 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 77,500 | — | $0 | 77,500 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise deriv | 2026-04-10 | 2026-04-13 | 19,021 | — | $0 | 455,920 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise | 2026-04-10 | 2026-04-13 | 19,021 | $1.71 | $32.5K | 1,336,410 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2026-04-10 | 2026-04-13 | 200,000 | $4.46 | $892.0K | 1,136,410 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2026-01-26 | 2026-01-27 | 26,918 | $4.61 | $124.1K | 1,317,389 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2026-01-23 | 2026-01-27 | 89,132 | $4.75 | $423.4K | 1,344,307 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2026-01-12 | 2026-01-14 | 274,000 | — | $0 | 274,000 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise deriv | 2026-01-12 | 2026-01-14 | 88,676 | — | $0 | 474,941 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise deriv | 2026-01-12 | 2026-01-14 | 111,324 | — | $0 | 111,359 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award | 2026-01-12 | 2026-01-14 | 427,000 | — | $0 | 1,433,439 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2026-01-12 | 2026-01-14 | 200,000 | $4.71 | $942.0K | 1,006,439 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise | 2026-01-12 | 2026-01-14 | 111,324 | $0.70 | $77.9K | 1,117,763 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise | 2026-01-12 | 2026-01-14 | 88,676 | $1.71 | $151.6K | 1,206,439 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise deriv | 2025-12-01 | 2025-12-01 | 260,047 | — | $0 | 563,617 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise | 2025-12-01 | 2025-12-01 | 260,047 | $1.71 | $444.7K | 1,266,486 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2025-12-01 | 2025-12-01 | 260,047 | $4.51 | $1.17M | 1,006,439 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise deriv | 2025-11-28 | 2025-12-01 | 39,953 | — | $0 | 823,664 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise deriv | 2025-11-28 | 2025-12-01 | 70,172 | — | $0 | 222,683 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise | 2025-11-28 | 2025-12-01 | 70,172 | $0.70 | $49.1K | 1,076,611 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise | 2025-11-28 | 2025-12-01 | 39,953 | $1.71 | $68.3K | 1,116,564 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2025-11-28 | 2025-12-01 | 110,125 | $4.75 | $523.1K | 1,006,439 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise deriv | 2025-09-10 | 2025-09-12 | 41,150 | — | $0 | 292,855 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2025-09-10 | 2025-09-12 | 200,000 | $3.23 | $646.0K | 1,006,439 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | M Exercise | 2025-09-10 | 2025-09-12 | 41,150 | $0.70 | $28.8K | 1,206,439 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2025-08-21 | 2025-08-22 | 57,054 | $2.85 | $162.6K | 1,165,289 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 77,500 | — | $0 | 77,500 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2025-01-02 | 2025-01-03 | 324,500 | — | $0 | 324,500 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award | 2025-01-02 | 2025-01-03 | 324,500 | — | $0 | 1,222,343 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 34,400 | — | $0 | 34,400 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2024-01-02 | 2024-01-04 | 863,617 | — | $0 | 863,617 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award | 2024-01-02 | 2024-01-04 | 863,617 | — | $0 | 897,843 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2023-12-14 | 2023-12-18 | 334,005 | — | $0 | 334,005 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 9,650 | — | $0 | 9,650 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2023-05-16 | 2023-05-18 | 5,000 | $0.68 | $3.4K | 34,226 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2022-12-30 | 2023-01-04 | 790,093 | — | $0 | 790,093 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-12-13 | 2022-12-15 | 9,650 | — | $0 | 9,650 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2022-06-17 | 2022-06-22 | 15,500 | — | $0 | 15,500 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 51,000 | — | $0 | 51,000 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2022-02-02 | 2022-02-03 | 10,000 | $8.01 | $80.1K | 29,226 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2021-06-17 | 2021-06-21 | 15,500 | — | $0 | 15,500 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2021-06-16 | 2021-06-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion deriv | 2020-09-28 | 2020-09-30 | 17,647 | — | $0 | 0 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion | 2020-09-28 | 2020-09-30 | 19,226 | — | $0 | 19,226 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2020-09-23 | 2020-09-25 | 31,000 | — | $0 | 31,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2020-06-16 | 2020-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2020-06-16 | 2020-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award | 2019-07-25 | 2019-07-29 | 32,258 | $4.65 | $150.0K | 34,258 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2019-06-13 | 2019-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2018-12-13 | 2018-12-17 | 17,240 | — | $0 | 17,240 | SEC↗ |
| SLDB Solid Biosciences Inc. | A Award deriv | 2018-09-12 | 2018-09-13 | 2,760 | — | $0 | 2,760 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 9,906 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 25,200 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2018-05-15 | 2018-05-15 | 9,906 | — | $0 | 9,906 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 15,000 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 37,750 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 178,494 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer | 2018-05-15 | 2018-05-15 | 3,800 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2018-03-13 | 2018-03-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AVXS AveXis, Inc. | A Award | 2018-03-13 | 2018-03-27 | 3,800 | — | $0 | 3,800 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2018-03-01 | 2018-03-05 | 1,780 | $18.47 | $32.9K | 1,780 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-01 | 2018-03-05 | 120 | $123.16 | $14.8K | 1,586 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-01 | 2018-03-05 | 175 | $124.29 | $21.8K | 1,411 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-01 | 2018-03-05 | 449 | $125.72 | $56.4K | 962 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-01 | 2018-03-05 | 504 | $126.95 | $64.0K | 458 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-01 | 2018-03-05 | 408 | $127.99 | $52.2K | 50 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-01 | 2018-03-05 | 50 | $128.91 | $6.4K | 0 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-01 | 2018-03-05 | 74 | $121.51 | $9.0K | 1,706 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2018-02-01 | 2018-02-05 | 1,780 | — | $0 | 180,274 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2018-02-01 | 2018-03-05 | 1,780 | — | $0 | 178,494 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-02-01 | 2018-02-05 | 17 | $122.83 | $2.1K | 0 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2018-02-01 | 2018-02-05 | 1,780 | $18.47 | $32.9K | 1,780 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-02-01 | 2018-02-05 | 1,001 | $117.12 | $117.2K | 779 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-02-01 | 2018-02-05 | 501 | $118.01 | $59.1K | 278 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-02-01 | 2018-02-05 | 3 | $118.96 | $357 | 275 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-02-01 | 2018-02-05 | 258 | $120.79 | $31.2K | 17 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2018-01-02 | 2018-01-04 | 1,780 | — | $0 | 182,054 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-01-02 | 2018-01-04 | 684 | $110.21 | $75.4K | 0 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2018-01-02 | 2018-01-04 | 1,780 | $18.47 | $32.9K | 1,780 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-01-02 | 2018-01-04 | 1,096 | $109.42 | $119.9K | 684 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2017-12-01 | 2017-12-05 | 1,780 | — | $0 | 183,834 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-12-01 | 2017-12-05 | 318 | $93.72 | $29.8K | 1,462 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-12-01 | 2017-12-05 | 1,327 | $94.92 | $126.0K | 135 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-12-01 | 2017-12-05 | 135 | $95.81 | $12.9K | 0 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2017-12-01 | 2017-12-05 | 1,780 | $18.47 | $32.9K | 1,780 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2017-11-01 | 2017-11-03 | 1,780 | — | $0 | 185,614 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-11-01 | 2017-11-03 | 205 | $105.02 | $21.5K | 70 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-11-01 | 2017-11-03 | 149 | $104.06 | $15.5K | 275 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-11-01 | 2017-11-03 | 42 | $102.00 | $4.3K | 424 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-11-01 | 2017-11-03 | 70 | $106.26 | $7.4K | 0 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-11-01 | 2017-11-03 | 431 | $100.05 | $43.1K | 1,097 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-11-01 | 2017-11-03 | 252 | $98.51 | $24.8K | 1,528 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2017-11-01 | 2017-11-03 | 1,780 | $18.47 | $32.9K | 1,780 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-11-01 | 2017-11-03 | 631 | $100.70 | $63.5K | 466 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2017-10-02 | 2017-10-03 | 1,780 | — | $0 | 187,394 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-10-02 | 2017-10-03 | 170 | $99.26 | $16.9K | 0 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-10-02 | 2017-10-03 | 385 | $98.77 | $38.0K | 170 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-10-02 | 2017-10-03 | 587 | $96.98 | $56.9K | 555 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-10-02 | 2017-10-03 | 638 | $96.05 | $61.3K | 1,142 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2017-10-02 | 2017-10-03 | 1,780 | $18.47 | $32.9K | 1,780 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2017-09-01 | 2017-09-05 | 1,780 | — | $0 | 189,174 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-09-01 | 2017-09-05 | 574 | $93.91 | $53.9K | 0 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-09-01 | 2017-09-05 | 1,206 | $92.93 | $112.1K | 574 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2017-09-01 | 2017-09-05 | 1,780 | $18.47 | $32.9K | 1,780 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2017-08-01 | 2017-08-03 | 1,780 | — | $0 | 190,954 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-08-01 | 2017-08-03 | 696 | $91.92 | $64.0K | 17 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-08-01 | 2017-08-03 | 1,067 | $91.24 | $97.4K | 713 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2017-08-01 | 2017-08-03 | 1,780 | $18.47 | $32.9K | 1,780 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-08-01 | 2017-08-03 | 17 | $92.75 | $1.6K | 0 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2017-07-03 | 2017-07-05 | 1,780 | — | $0 | 192,734 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2017-07-03 | 2017-07-05 | 1,780 | $18.47 | $32.9K | 1,780 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-07-03 | 2017-07-05 | 299 | $82.28 | $24.6K | 0 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-07-03 | 2017-07-05 | 1,481 | $81.80 | $121.1K | 299 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2017-06-01 | 2017-06-02 | 1,780 | — | $0 | 194,514 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-06-01 | 2017-06-02 | 633 | $70.20 | $44.4K | 1,147 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-06-01 | 2017-06-02 | 977 | $71.19 | $69.6K | 170 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-06-01 | 2017-06-02 | 170 | $71.91 | $12.2K | 0 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2017-06-01 | 2017-06-02 | 1,780 | $18.47 | $32.9K | 1,780 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2017-05-10 | 2017-05-12 | 25,200 | — | $0 | 25,200 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2017-05-01 | 2017-05-02 | 1,780 | — | $0 | 196,294 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-05-01 | 2017-05-02 | 576 | $81.91 | $47.2K | 22 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-05-01 | 2017-05-02 | 22 | $82.58 | $1.8K | 0 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2017-05-01 | 2017-05-02 | 1,780 | $18.47 | $32.9K | 1,780 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-05-01 | 2017-05-02 | 1,182 | $81.11 | $95.9K | 598 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2017-04-03 | 2017-04-05 | 1,781 | — | $0 | 198,074 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2017-04-03 | 2017-04-05 | 1,781 | $76.13 | $135.6K | 0 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2017-04-03 | 2017-04-05 | 1,781 | $18.47 | $32.9K | 1,781 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2016-06-20 | 2016-06-22 | 37,750 | — | $0 | 37,750 | SEC↗ |